Table 1.
Patient clinicopathology characteristics.
| Characteristic | n = 231 |
|---|---|
| Age | |
| <50 | 50 (21.65%) |
| ≥50 | 181 (78.35%) |
| Sex | |
| Female | 119 (51.52%) |
| Male | 112 (48.48%) |
| Tumor Site | |
| Left | 180 (77.92%) |
| Right | 50 (21.65%) |
| Unknown | 1 (0.43%) |
| Stage | |
| I | 11 (4.76%) |
| II | 66 (28.57%) |
| III | 56 (24.24%) |
| IV | 92 (39.83%) |
| Unknown | 6 (2.60%) |
| T Status | |
| 1 | 2 (0.87%) |
| 2 | 25 (10.82%) |
| 3 | 150 (64.94%) |
| 4 | 53 (22.94%) |
| x | 1 (0.43%) |
| N Status | |
| 0 | 115 (49.78%) |
| 1 | 80 (34.63%) |
| 2 | 30 (12.99%) |
| x | 6 (2.60%) |
| Metastatic Status | |
| 0 | 134 (58.01%) |
| 1 | 91 (39.39%) |
| x | 6 (2.60%) |
| Histological Grading | |
| 1 | 103 (44.59%) |
| 2 | 91 (39.39%) |
| 3 | 32 (13.85%) |
| 4 | 2 (0.87%) |
| Unknown | 3 (1.30%) |
| Lymphovascular Status | |
| 0 | 51 (22.08%) |
| 1 | 58 (25.11%) |
| Unknown | 122 (52.81%) |
| Pathological Morphology | |
| Adenocarcinoma | 226 (97.84%) |
| Mucinous Carcinoma | 5 (2.16%) |
| TILs | |
| Low | 42 (18.18%) |
| Medium | 74 (32.03%) |
| High | 76 (32.90%) |
| Unknown | 39 (16.88%) |
| Hemoglobin level (g/dL) | |
| <10 | 27 (11.69%) |
| ≥10 | 196 (84.85%) |
| Unknown | 8 (3.46%) |
| Serum albumin (g/dL) | |
| <3.5 | 98 (42.42%) |
| >3.5 | 64 (27.71%) |
| Unknown | 69 (29.87%) |
| ECOG | |
| ECOG 0–1 | 147 (63.64%) |
| ECOG 2 | 36 (15.58%) |
| ECOG 3–4 | 19 (8.23%) |
| Unknown | 29 (12.55%) |
| BMI (kg/m2) | |
| <18.5 | 71 (30.74%) |
| 18.5–22.9 | 90 (38.96%) |
| 23–24.9 | 31 (13.42%) |
| ≥25 | 30 (12.99%) |
| Unknown | 9 (3.90%) |